Cargando…

Botulinum Neurotoxin for the Treatment of Neuropathic Pain

Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders. This review summarizes the evidence from the published literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Egeo, Gabriella, Fofi, Luisa, Barbanti, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431775/
https://www.ncbi.nlm.nih.gov/pubmed/32849195
http://dx.doi.org/10.3389/fneur.2020.00716
_version_ 1783571655189069824
author Egeo, Gabriella
Fofi, Luisa
Barbanti, Piero
author_facet Egeo, Gabriella
Fofi, Luisa
Barbanti, Piero
author_sort Egeo, Gabriella
collection PubMed
description Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders. This review summarizes the evidence from the published literature regarding its effect on neuropathic pain. Almost all investigations were performed using onabotulinum toxin type A (BoNT/A). Most studies provided positive results, even though toxin formulation, dose, dilution, injection techniques, and sites are heterogeneous across studies. Future larger, high-quality, specifically designed clinical trials are warranted to confirm botulinum neurotoxin efficacy in neuropathic pain.
format Online
Article
Text
id pubmed-7431775
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74317752020-08-25 Botulinum Neurotoxin for the Treatment of Neuropathic Pain Egeo, Gabriella Fofi, Luisa Barbanti, Piero Front Neurol Neurology Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders. This review summarizes the evidence from the published literature regarding its effect on neuropathic pain. Almost all investigations were performed using onabotulinum toxin type A (BoNT/A). Most studies provided positive results, even though toxin formulation, dose, dilution, injection techniques, and sites are heterogeneous across studies. Future larger, high-quality, specifically designed clinical trials are warranted to confirm botulinum neurotoxin efficacy in neuropathic pain. Frontiers Media S.A. 2020-08-11 /pmc/articles/PMC7431775/ /pubmed/32849195 http://dx.doi.org/10.3389/fneur.2020.00716 Text en Copyright © 2020 Egeo, Fofi and Barbanti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Egeo, Gabriella
Fofi, Luisa
Barbanti, Piero
Botulinum Neurotoxin for the Treatment of Neuropathic Pain
title Botulinum Neurotoxin for the Treatment of Neuropathic Pain
title_full Botulinum Neurotoxin for the Treatment of Neuropathic Pain
title_fullStr Botulinum Neurotoxin for the Treatment of Neuropathic Pain
title_full_unstemmed Botulinum Neurotoxin for the Treatment of Neuropathic Pain
title_short Botulinum Neurotoxin for the Treatment of Neuropathic Pain
title_sort botulinum neurotoxin for the treatment of neuropathic pain
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431775/
https://www.ncbi.nlm.nih.gov/pubmed/32849195
http://dx.doi.org/10.3389/fneur.2020.00716
work_keys_str_mv AT egeogabriella botulinumneurotoxinforthetreatmentofneuropathicpain
AT fofiluisa botulinumneurotoxinforthetreatmentofneuropathicpain
AT barbantipiero botulinumneurotoxinforthetreatmentofneuropathicpain